Windtree Therapeutics Initiates SEISMiC C Study Of Istaroxime In SCAI Stage C Cardiogenic Shock For Planned Completion Of Phase 2b And Transition To Phase 3

BenzingaOct 30 08:16 ET

Express News | Windtree Therapeutics Initiates Seismic C Study of Istaroxime in Scai Stage C Cardiogenic Shock for Planned Completion of Phase 2B and Transition to Phase 3

ReutersOct 30 08:00 ET

Express News | Windtree Therapeutics Inc - May Sell & Issue Shares to Seven Knots From Time to Time Under Equity Line

ReutersOct 28 17:15 ET

Express News | Windtree Therapeutics Inc - Files Prospectus Supplement for $27.2 Mln Stock Sale

ReutersOct 28 17:15 ET

Express News | Windtree Completes National Phase Filings Of Patent Applications In US, Germany, France, Italy, Japan And China

BenzingaOct 23 08:13 ET

Windtree Announces Expansion Of Patents With Issuance Of Istaroxime Patent For Japan

BenzingaOct 17 08:18 ET